Psychometric evaluation of the Swedish self-rated 36-item version of WHODAS 2.0 for use in psychiatric populations - using classical test theory.


Journal

Nordic journal of psychiatry
ISSN: 1502-4725
Titre abrégé: Nord J Psychiatry
Pays: England
ID NLM: 100927567

Informations de publication

Date de publication:
Oct 2021
Historique:
pubmed: 11 5 2021
medline: 14 10 2021
entrez: 10 5 2021
Statut: ppublish

Résumé

The aim of this study was to evaluate the reliability and validity of the Swedish version of the self-rated 36-item WHODAS 2.0 in patients from Swedish psychiatric outpatient settings, using classical test theory. The 36-item WHODAS 2.0, together with the Sheehan Disability Scale (SDS), was filled in by a sample of 780 participating psychiatric patients: 512 (65.6%) women, 263 (33.7%) men, and 5 (0.6%) who did not report any sex. The internal consistency, measured by Cronbach's alpha, for the different domains of functioning were between 0.70 and 0.94, and interpreted as good. The confirmatory factor analysis (CFA) revealed two levels: the first level consisted of a general disability factor, while the second level consisted of the six domains of the scale, respectively. The model had borderline fit. There was a significant correlation between WHODAS 2.0 36-item and SDS ( The present study demonstrates that the Swedish self-rated 36-item version of WHODAS 2.0, within a psychiatric outpatient population, showed good reliability and convergent validity. We conclude that the self-rated 36-item Swedish version of WHODAS 2.0 can be used for valid interpretations of disability in patients with psychiatric health conditions.

Identifiants

pubmed: 33969799
doi: 10.1080/08039488.2021.1897162
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

494-501

Auteurs

Robin Midhage (R)

Department of Neuroscience, Psychiatry, Uppsala University, Uppsala, Sweden.

Liselotte Hermansson (L)

Faculty of Medicine and Health, University Health Care Research Center, Örebro University, Örebro, Sweden.

Per Söderberg (P)

Department of Psychiatric Research and Development, Säter, Sweden.

Stefan Tungström (S)

Department of Psychiatric Research and Development, Säter, Sweden.

Axel Nordenskjöld (A)

Faculty of Medicine and Health, University Health Care Research Center, Örebro University, Örebro, Sweden.

Cecilia Svanborg (C)

Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden.

Ylva Ginsberg (Y)

Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden.
The National Board of Health and Welfare, Stockholm, Sweden.

Mia Ramklint (M)

Department of Neuroscience, Psychiatry, Uppsala University, Uppsala, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH